Allopurinol sodium
Allopurinol Sodium is a prescription injectable medication, available as a lyophilized powder for intravenous solution. Each vial contains 500 mg of allopurinol sodium, equivalent to 500 mg base. It's a xanthine oxidase inhibitor used to manage conditions like gout. Manufactured by Hikma Pharmaceuticals USA Inc. under ANDA 076870. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Allopurinol Sodium is a prescription injectable medication, available as a lyophilized powder for intravenous solution. Each vial contains 500 mg of allopurinol sodium, equivalent to 500 mg base. It's a xanthine oxidase inhibitor used to manage conditions like gout. Manufactured by Hikma Pharmaceuticals USA Inc. under ANDA 076870. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Allopurinol sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Allopurinol sodium — ANDA 076870 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076870"
}
]
|
| identifier | ANDA076870 |
| issued | 2016-09-16 |
| keyword |
[
"health-care",
"medications",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Allopurinol sodium |
